SGX Google Yahoo TradingView

HYPHENS PHARMA INTL LIMITED (1J5) SGD 0.335   +2.99% +0.01

Portfolio Watchlist
AllFinancialBuy BackInsider Trading

Hyphens Pharma

2024-04-19
REPL::Annual General Meeting::Voluntary

Hyphens Pharma

2024-04-08
Cash Dividend/ Distribution::Mandatory

Hyphens Pharma

2024-04-08
Annual General Meeting::Voluntary

Hyphens Pharma

2024-04-08
Annual Reports and Related Documents::

Hyphens Pharma

2024-04-02
Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice

Hyphens Pharma

2024-04-02
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING

Hyphens Pharma

2024-03-25
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - MR CHAN KIAT

Hyphens Pharma

2024-03-22
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING

Hyphens Pharma

2024-03-12
General Announcement::HYPHENS PHARMA LICENSES WYNZORA CREAM FOR ASEAN COUNTRIES FROM MC2 THERAPEUTICS

Hyphens Pharma

2024-03-06
General Announcement::RESULTS BRIEFING FY2023

Hyphens Pharma

2024-02-29
General Announcement::HYPHENS PHARMA'S CERADAN RANGE OF PRODUCTS TO ENTER MAJOR MIDDLE EAST MARKETS

Hyphens Pharma

2024-02-27
Financial Statements and Related Announcement::Full Yearly Results

Hyphens Pharma

2024-02-06
General Announcement::HYPHENS PHARMA PARTNERS 7-ELEVEN TO OFFER OCEAN HEALTH SUPPLEMENTS IN SINGAPORE

Hyphens Pharma

2023-12-08
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO THE HYPHENS SHARE PLAN

Hyphens Pharma

2023-11-09
General Announcement::QUARTERLY BUSINESS UPDATE FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2023

Hyphens Pharma

2023-11-08
Asset Acquisitions and Disposals::COMPLETION OF PROPOSED ACQUISITION OF THE TRANCHE 1 SALE SHARES OF 23% IN ARDENCE PHARMA SDN BHD

Hyphens Pharma

2023-10-19
General Announcement::ANALYST BRIEFING- ACQUISITION OF ARDENCE MALAYSIA

Hyphens Pharma

2023-10-17
Asset Acquisitions and Disposals::PROPOSED ACQUISITION OF 58% OF THE SHARE CAPITAL IN ARDENCE PHARMA SDN BHD OVER 3 TRANCHES

Hyphens Pharma

2023-08-30
General Announcement::NABOTA SUCCESSFULLY REGISTERED IN MALAYSIA

Hyphens Pharma

2023-08-17
General Announcement::RESULTS BRIEFING 1H 2023

Hyphens Pharma

2023-08-10
Cash Dividend/ Distribution::Mandatory

Hyphens Pharma

2023-08-10
Financial Statements and Related Announcement::Half Yearly Results

Hyphens Pharma

2023-07-19
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::CESSATION OF SUBSTANTIAL SHAREHOLDER'S INTEREST- MR TAN CHWEE CHOON

Hyphens Pharma

2023-07-19
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING

Hyphens Pharma

2023-07-19
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - MR LIM SEE WAH

Hyphens Pharma

2023-07-19
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::CHANGE OF SUBSTANTIAL SHAREHOLDER'S INTEREST - INOMED HOLDING PTE LTD

Hyphens Pharma

2023-06-05
Change - Announcement of Appointment::Appointment of Chief Financial Officer

Hyphens Pharma

2023-05-24
General Announcement::Minutes of Annual General Meeting and Extraordinary General Meeting held on 26 April 2023

Hyphens Pharma

2023-05-17
General Announcement::HYPHENS PHARMA TO DEVELOP AND COMMERCIALISE BYFAVO PROCEDURAL SEDATION DRUG IN SINGAPORE

Hyphens Pharma

2023-05-11
General Announcement::BUSINESS UPDATE AND RESULTS BRIEFING FOR THE FIRST QUARTER ENDED 31 MARCH 2023

Hyphens Pharma

2023-04-28
Employee Stock Option/ Share Scheme::ALLOTMENT AND ISSUANCE OF 422,000 NEW ORDINARY SHARES UNDER THE HYPHENS PERFORMANCE SHARE PLAN

Hyphens Pharma

2023-04-26
REPL::Extraordinary/ Special General Meeting::Voluntary

Hyphens Pharma

2023-04-26
REPL::Annual General Meeting::Voluntary

Hyphens Pharma

2023-04-20
General Announcement::RESPONSE TO QUERIES FROM SECURITIES INVESTORS ASSOCIATION (SINGAPORE) ON ANNUAL REPORT 2022

Hyphens Pharma

2023-04-20
REPL::Annual General Meeting::Voluntary

Hyphens Pharma

2023-04-09
Change - Announcement of Cessation::Cessation of an Executive Director

Hyphens Pharma

2023-04-09
Cash Dividend/ Distribution::Mandatory

Hyphens Pharma

2023-04-09
Extraordinary/ Special General Meeting::Voluntary

Hyphens Pharma

2023-04-09
Annual General Meeting::Voluntary

Hyphens Pharma

2023-04-09
Annual Reports and Related Documents::

Hyphens Pharma

2023-03-06
General Announcement::RESULTS BRIEFING FY2022

Hyphens Pharma

2023-02-28
Financial Statements and Related Announcement::Full Yearly Results

Hyphens Pharma

2023-02-10
General Announcement::NABOTA SUCCESSFULLY REGISTERED IN SINGAPORE

Hyphens Pharma

2022-12-20
General Announcement::HYPHENS PHARMA LICENSES WINLEVI FOR ALL 10 ASEAN COUNTRIES FROM COSMO PHARMACEUTICALS

Hyphens Pharma

2022-12-05
General Announcement::HYPHENS PHARMA'S MERADAN CREAM LAUNCHES IN INDONESIA

Hyphens Pharma

2022-11-09
General Announcement::QUARTERLY BUSINESS UPDATE FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2022

Hyphens Pharma

2022-09-15
General Announcement::Hyphens Pharma TDF Blu Voile Sunscreen

Hyphens Pharma

2022-08-17
General Announcement::RESULTS BRIEFING 1H 2022

Hyphens Pharma

2022-08-11
Financial Statements and Related Announcement::Half Yearly Results

Hyphens Pharma

2022-06-06
General Announcement::COMPLETION OF INVESTMENT IN DOCMED TECHNOLOGY

© 2026 Dividends.sg